Cited by 491Blood Pressure and Hypertension StudiesCardiovascular Health and Disease PreventionSodium Intake and Health

Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes

Open access
Yang, Wen-Yi, Melgarejo, Jesus D., Thijs, Lutgarde, Zhang, Zhen-Yu, Boggia, José, Wei, Fang-Fei, Hansen, Tine W., Asayama, Kei +19 more·2019·JAMA

Abstract

Importance: Blood pressure (BP) is a known risk factor for overall mortality and cardiovascular (CV)-specific fatal and nonfatal outcomes. It is uncertain which BP index is most strongly associated with these outcomes. Objective: To evaluate the association of BP indexes with death and a composite CV event. Design, Setting, and Participants: Longitudinal population-based cohort study of 11 135 adults from Europe, Asia, and South America with baseline observations collected from May 1988 to May 2010 (last follow-ups, August 2006-October 2016). Exposures: Blood pressure measured by an observer or an automated office machine; measured for 24 hours, during the day or the night; and the dipping ratio (nighttime divided by daytime readings). Main Outcomes and Measures: Multivariable-adjusted hazard ratios (HRs) expressed the risk of death or a CV event associated with BP increments of 20/10 mm Hg. Cardiovascular events included CV mortality combined with nonfatal coronary events, heart failure, and stroke. Improvement in model performance was assessed by the change in the area under the curve (AUC). Results: Among 11 135 participants (median age, 54.7 years, 49.3% women), 2836 participants died (18.5 per 1000 person-years) and 2049 (13.4 per 1000 person-years) experienced a CV event over a median of 13.8 years of follow-up. Both end points were significantly associated with all single systolic BP indexes (P < .001). For nighttime systolic BP level, the HR for total mortality was 1.23 (95% CI, 1.17-1.28) and for CV events, 1.36 (95% CI, 1.30-1.43). For the 24-hour systolic BP level, the HR for total mortality was 1.22 (95% CI, 1.16-1.28) and for CV events, 1.45 (95% CI, 1.37-1.54). With adjustment for any of the other systolic BP indexes, the associations of nighttime and 24-hour systolic BP with the primary outcomes remained statistically significant (HRs ranging from 1.17 [95% CI, 1.10-1.25] to 1.87 [95% CI, 1.62-2.16]). Base models that included single systolic BP indexes yielded an AUC of 0.83 for mortality and 0.84 for the CV outcomes. Adding 24-hour or nighttime systolic BP to base models that included other BP indexes resulted in incremental improvements in the AUC of 0.0013 to 0.0027 for mortality and 0.0031 to 0.0075 for the composite CV outcome. Adding any systolic BP index to models already including nighttime or 24-hour systolic BP did not significantly improve model performance. These findings were consistent for diastolic BP. Conclusions and Relevance: In this population-based cohort study, higher 24-hour and nighttime blood pressure measurements were significantly associated with greater risks of death and a composite CV outcome, even after adjusting for other office-based or ambulatory blood pressure measurements. Thus, 24-hour and nighttime blood pressure may be considered optimal measurements for estimating CV risk, although statistically, model improvement compared with other blood pressure indexes was small.

Integrity signals

Registry

Crossref · 10.1001/jama.2019.9811

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yang, W.-Y., Melgarejo, J. D., Thijs, L., Zhang, Z.-Y., Boggia, J., Wei, F.-F., Hansen, T. W., Asayama, K., Ohkubo, T., Jeppesen, J., Dolan, E., Stolarz-Skrzypek, K., Malyutina, S., Casiglia, E., Lind, L., Filipovský, J., Maestre, G. E., Li, Y., Wang, J.-G., Imai, Y., Kawecka-Jaszcz, K., Sandoya, E., Narkiewicz, K., O’Brien, E., Verhamme, P., Staessen, J. A., & for The International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators
Affiliations
  • Shanghai Jiao Tong University (CN)
  • Laboratorio de Neurociencias and Instituto Cardiovascular, Universidad del Zulia, Maracaibo, Venezuela
  • KU Leuven (BE)
  • Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay
  • Steno Diabetes Center Copenhagen (DK)
  • Tohoku Institute for Management of Blood Pressure (JP)
  • University of Copenhagen (DK)
  • Addenbrooke's Hospital (GB)
  • The First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland
  • Institute of Cytology and Genetics (RU)
  • University of Padua (IT)
  • Uppsala University (SE)
  • Charles University (CZ)
  • Universidad del Zulia (VE)
  • Asociación Española Primera en Salud, Montevideo, Uruguay
  • Gdańsk Medical University (PL)
  • Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland
  • Maastricht University (NL)
Corresponding author
Staessen, Jan A.
Venue
JAMA
Published
2019-08-06
Volume
322
Issue
5
Pages
409
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2966011904
Cited by
491
References
5
Citations by year
2026: 47 · 2025: 74 · 2024: 85 · 2023: 75 · 2022: 63 · 2021: 71 · 2020: 63 · 2019: 13
FWCI
37.96
Type
journal article
Language
en
Open access
Locations
  • JAMA (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • Lirias (submittedVersion, other-oa)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion, cc-by-nc-nd)
  • Jagiellonian University Repository (Jagiellonian University) (submittedVersion, other-oa)
  • Homo Politicus (Academy of Humanities and Economics in Lodz) (submittedVersion)
  • ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley) (submittedVersion)
Funders
  • Pfizer (15XD1503200)
  • Univerzita Karlova v Praze
  • Hjerteforeningen (01-2-9-9A-22914)
  • Showa Pharmaceutical University
  • Steno Diabetes Center Copenhagen (SDCC 3.A Complications)
  • European Commission (LSHM-CT-2006-037093, G.0881.13, 201550, 713601, 2011-294713-EPLORE, 305507)
  • National Natural Science Foundation of China (91639203, 81170245, 81470533, 81270373, 2013CB530700)
  • Fundacja na rzecz Nauki Polskiej
  • Fonds Wetenschappelijk Onderzoek (G.0881.13)
  • Ministry of Agriculture, Forestry and Fisheries (NouEi 2-02)
  • Fondo Nacional de Ciencia Tecnología e Innovación (R01AG036469, G‐97000726)
  • Vlaamse regering
  • H. Lundbeck A/S
  • National Institutes of Health (G-97000726)
  • Pfizer Japan
  • Chugai Pharmaceutical
  • Japan Society for the Promotion of Science (16K15359, 17H04126)
  • National Institute on Aging (R01AG036469, R03AG054186, P30AG066546)
  • Fogarty International Center
  • Daiichi Sankyo Europe
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
Keywords
blood pressure, ambulatory blood pressure, office blood pressure, 24-hour ambulatory blood pressure, nocturnal blood pressure, systolic blood pressure, cardiovascular mortality, cardiovascular events, heart failure, stroke, coronary events, cardiovascular risk prediction, cardiovascular risk score
MeSH terms
Adult, Blood Pressure, Blood Pressure Determination, Cardiovascular Diseases, Circadian Rhythm, Female, Humans, Hypertension, Longitudinal Studies, Male, Middle Aged, Risk Factors, Proportional Hazards Models, Blood Pressure Monitoring, Ambulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review